Elanco Names Todd S. Young as New Chief Financial Officer
30 October 2018 - 9:30PM
Business Wire
Young to join Indiana-based Animal Health
Company’s Leadership Team
Regulatory News:
Elanco Animal Health Incorporated (NYSE:ELAN), today named Todd
S. Young as executive vice president and chief financial officer
(CFO), joining Elanco’s Executive Committee and reporting to Elanco
president and chief executive officer, Jeffrey N. Simmons.
Young starts his new position at Elanco on November 1 at the
company’s Greenfield, Indiana headquarters. Lucas Montarce, who has
been serving as acting Elanco CFO, will return to Eli Lilly and
Company as vice president and CFO of Lilly’s International Business
Unit.
“I am pleased to welcome Todd to the Elanco Executive Team,”
said Jeff Simmons, president and CEO of Elanco. “His deep financial
expertise combined with his pharmaceutical industry knowledge make
him an excellent addition to Elanco at this exciting time in our
company’s history. We also thank Lucas Montarce for his dedication
and commitment stepping in during a critical time.”
Young will have responsibility for Elanco’s financial
operations. He has more than 20 years’ experience in a wide range
of financial roles. Most recently, he was executive vice president
and CFO for ACADIA Pharmaceuticals Inc. in San Diego. He also spent
several years in varying financial leader roles at Baxter
International and worked on the spin-off of Baxalta, which he then
joined as senior vice president and treasurer. He started his
career at law firm Sidley Austin L.L.P.
Over the past 20 years, Young has had experience in all sectors
of corporate financial operations, including tax, treasury, mergers
and acquisitions, and leading and building finance teams. He also
spent time in international markets throughout his career.
About Elanco Animal Health
Elanco (NYSE: ELAN) is a global animal health company that
develops products and knowledge services to prevent and treat
disease in food animals and pets in more than 90 countries. With a
64-year heritage, we rigorously innovate to improve the health of
animals and benefit our customers, while fostering an inclusive,
cause-driven culture for more than 5,800 employees. At Elanco,
we’re driven by our vision of food and companionship enriching life
– all to advance the health of animals, people and the planet.
Learn more at www.elanco.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181030005325/en/
Media:Elanco Animal Health IncorporatedColleen Parr
Dekker, 1-317-989-7011parr_dekker_colleen@elanco.com
Elanco Animal Health (NYSE:ELAN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elanco Animal Health (NYSE:ELAN)
Historical Stock Chart
From Jul 2023 to Jul 2024